CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
105908-71-2 | | 1-Bromodibenzo-p-dioxin | C12H7BrO2 | 263.09 | | |
105908-83-6 | | 4-(2-chlorophenylcarbamoyl)morpholine | | | | |
105909-12-4 | | 2,5-dimethyl-4-methoxyphenylacetonitrile | | | | |
105909-52-2 | | 3-chloro-n-(2-methoxybenzyl)propanamide | | | | |
105909-88-4 | | 2-benzyl-n-methyl-succinimid | | | | |
105909-93-1 | 5-甲氧基-1,2-二甲基-1h-吲哚-3-羧酸 | 5-methoxy-1,2-dimethyl-1h-indole-3-carboxylic acid | | | | |
10591-31-8 | | diacetyldeuteroporphyrin ix dimethyl ester | C36H38N4O6 | 622.72 | | |
10591-85-2 | 四苄基秋兰姆化二硫 | Tetrabenzylthiuram disulfide | | | | |
105911-31-7 | | 2-chloro-5-ethyl-2,4,4-trimethyl-heptane | C12H25Cl | 204.78 | | |
105911-32-8 | | 2-chloro-2,4,4,5-tetramethyl-octane | C12H25Cl | 204.78 | | |
1059126-74-7 | 2-氨基-6-甲基噻吩并[2,3-d]嘧啶-4(1h)-酮 | 2-amino-6-methylthieno[2,3-d]pyrimidin-4(1h)-one | | | | |
105913-11-9 | | plasminogen activator | | | | |
105916-31-2 | | 5h)-pyrimidinedione, 6-(methylthio)-5,5-dipropyl-4(3h | | | | |
105916-34-5 | | 3-(diphenylamino)-2-hydroxy-n,n-dimethyl-n-(1-methylethyl)-1-propanaminiu i | | | | |
105916-35-6 | | benzenemethanaminium, 2-chloro-n-(2-hydroxy-3-((2,4,6-trimethylphenyl)amino)pro | | | | |
105917-76-8 | | 2,3-dichloro-4-(ethylsulfonyl)benzenecarboxylic acid | | | | |
1059179-65-5 | 2,7-二溴-9,9-双(4-己基苯基)-9h-芴 | 2,7-dibromo-9,9-bis(4-hexylphenyl)-9h-fluorene | | | | |
105918-76-1 | | n-homocysteine thiolactonyl retinamide | | | | |
105918-81-8 | | (((ethylamino)carbonyl)amino)oxo-acetic aci monoammonium salt | | | | |
105918-90-9 | | ((butylaminocarbonyl)amino)oxo-acetic aci methyl ester | | | | |
105919-34-4 | 顺式-2-氟环丙烷羧酸 | cis-2-fluorocyclopropanecarboxylic acid | | | | |
105919-37-7 | | 2-methyl-1-(1-oxo-3-(4-(trifluoromethyl)phenyl)-2-propenyl)-piperidin | | | | |
105919-38-8 | | 3-methyl-4-(1-oxo-3-(4-(trifluoromethyl)phenyl)-2-propenyl)-morpholin | | | | |
105919-39-9 | | 1-(3-(4-chlorophenyl)-1-oxo-2-propenyl)-2-methyl-piperidin | | | | |
105919-40-2 | | 1-(3-(4-fluorophenyl)-1-oxo-2-propenyl)-2-methyl-piperidin | | | | |
105919-41-3 | | 2,6-dimethyl-1-(1-oxo-3-(4-(trifluoromethyl)phenyl)-2-propenyl)-piperidin | | | | |
105919-42-4 | | 4-(3-(4-fluorophenyl)-1-oxo-2-propenyl)-morpholin | | | | |
105919-43-5 | | 4-(1-oxo-3-(4-(trifluoromethyl)phenyl)-2-propenyl)-morpholin | | | | |
105919-44-6 | | 4-methyl-1-(1-oxo-3-(4-(trifluoromethyl)phenyl)-2-propenyl)-piperidin | | | | |
10592-04-8 | | (5-chloro-6-iodo-5-decenylene)bis(trimethyl-ammoniu dichloride | | | | |
10592-13-9 | | 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro- 3,5 | C22H25ClN2O8 | 480.90 | | |
10592-27-5 | | 2,3-dihydro-7-azaindole | | | | |
10592-65-1 | | quingestanol | | | | |
105920-77-2 | | camonagrel | | | | |
105923-30-6 | | n-(2-bromo-4-nitrophenyl)-2,3,3,3-tetrafluoro-2-(trifluoromethyl)-propanamid | | | | |
105923-55-5 | | n,n,n-tripropyl-, salt with n-(2-bromo-4-nitrophenyl)-2,3,3,3-1-propanaminiu | | | | |
105923-79-3 | | pentanamide, n-(2-bromo-4-nitrophenyl)-2,3,3,4,4,5,5-octafluoro-2-(trifluoromet | | | | |
105924-64-9 | | 3,3,3-trifluoro-1-(phenylsulfonyl)-1-propene | | | 68-71℃ | |
105925-39-1 | | ihap1 | | | | |
105928-88-9 | | d-alanin | | | | |
10593-16-5 | | acetic acid, 1-naphthyl-, 2-dimethylaminoethyl ester, hydrochloride | | | | |
10593-17-6 | | n-(2-(dimethylamino)ethyl)-1-naphthaleneacetamid | | | | |
10593-29-0 | | 1-thio-b-d-glucose sodium | C6H11NaO5S | 218.20 | | |
10593-57-4 | | 4-b)indole, 1-methyl-7-propoxy-9h-pyrido( | | | | |
10593-60-9 | | n,n'-bis(1-methyl-4-piperidylmethyl)-terephthalamid hemihydrate | | | | |
10593-62-1 | | n,n'-bis(1-methyl-4-phenyl-4-piperidylmethyl)-terephthalamid dihydrochlorid | | | | |
10593-63-2 | | n,n'-bis(1-benzyl-4-phenyl-4-piperidylmethyl)-terephthalamid hemihdrate | | | | |
10593-78-9 | | 5,6,7,8-tetrahydro-pteridin | | | | |
10593-85-8 | | homocysteine thiolactone | | | | |
105931-25-7 | | prothrombin precursor (13-29 | | | | |